Rafarma Pharmaceuticals, Inc. announced the appointment of Vladimir Dolgolenko as its new CEO and President. Mr. Sreco Bojt shall remain as a company Director. Mr. Dolgolenko has major management expertise in the development and implementation of biotechnologies in degraded soil processing and recultivation, as well as the monetization of new biotechnologies in agriculture, crude oil refineries, and petroleum waste processing.

Mr. Dolgolenko brings to Rafarma tremendous management experience that will refine Rafarma's processes, enter new markets, and raise revenues toward a tremendous increase in shareholder value.